BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Norwich Pharmaceuticals: Handling Potent Compounds Safely


5/29/2012 11:48:03 AM

May 29, 2012 -- Norwich focuses on manufacturing potent, solid dose products, including fast dissolve and controlled release tablets, while also providing a range of analytical services in-house.

To survive in a highly competitive marketplace, all contract manufacturers must address the reality of potent compound safety. The result of improper handling of potent compounds can not only impede a drug’s release to market, but also may cause serious adverse health effects in employees who handle the drug.

Norwich’s leadership in the area of proper handling of potent compounds was recently tested when a customer presented a challenging process that required potent compound handling with the added complexity of flammable solvents. They took on the challenge and successfully designed, built and qualified a nitrogen blanketing system that provides fail-safe protection for handling hazardous compounds with solvents, which also can be leveraged in several other applications.

Norwich recognizes that protecting their customers’ drug-to-market timelines is its top priority and by proactively taking steps to prevent and control exposure, they ensured the health of their team too.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES